UK health research body backs trial data disclosure & access to patient data
This article was originally published in SRA
The UK's Health Research Authority has come out in favor of wider public disclosure of clinical trial results provided the data published are in an easily understood form and patient privacy is protected1.
You may also be interested in...
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.
Mutual recognition of approvals and simplified rules on labeling could help to make COVID-19 vaccines more accessible to populations around the world.
The UK BioIndustry Association says the updated guidance will result in duplicative and costly repetition and dent industry’s confidence in the government’s competence.